Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2012
04/04/2012EP2435421A1 Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
04/04/2012EP2435420A1 Pyrazinylpyrazoles
04/04/2012EP2435419A1 Substituted quinazolines as fungicides
04/04/2012EP2435411A1 2, 4 -diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
04/04/2012EP2435405A1 Substituted piperidines
04/04/2012EP2435404A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
04/04/2012EP2280959B1 4-amino-indazoles
04/04/2012EP1979341B1 Trisubstituted amine compound
04/04/2012EP1615878B1 Compounds, compositions and methods of treatment for heart failure
04/04/2012EP1565452B1 3-substituted-6-aryl pyridines as ligands of c5a receptors
04/04/2012EP1557414B1 Isoquinoline compounds and medicinal use thereof
04/04/2012EP0831941B1 Iodinated neuroprobes for mapping monoamine reuptake sites
04/04/2012CN1946695B 可用作杀真菌剂的2-吡啶基环烷基羧酰胺衍生物 Useful as fungicides 2- pyridyl cycloalkyl carboxamide derivatives
04/04/2012CN1930143B 具有微粒体甘油三酸酯传递蛋白质抑制活性的被五元杂环取代的芳基哌啶或哌嗪 Having microsomal triglyceride transfer protein inhibiting activity by five-membered heterocyclic aryl substituted piperidine or piperazine
04/04/2012CN102405219A Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of copd
04/04/2012CN102405218A Diamide compounds having muscarinic receptor antagonist and ss2 adrenergic receptor agonist activity
04/04/2012CN102405217A Azaazulene compounds
04/04/2012CN102405214A Preparation of c-pyrazine-methylamines
04/04/2012CN102405211A Proline derivatives as cathepsin inhibitors
04/04/2012CN102399212A 一种右兰索拉唑晶型及其制备方法 One kind Dexlansoprazole crystal and preparation method
04/04/2012CN102399211A 3-溴-1-(3-氯-2-吡啶基)-4,5-二氢-1h-吡唑-5-甲酸酯的制备方法 3-bromo-1- (3-chloro-2-pyridinyl) -4,5-dihydro--1h- pyrazole-5-carboxylate Preparation of
04/04/2012CN101921238B 取代苯并氮杂环类衍生物的制备及其药理用途 Benzazepine ring-substituted derivatives of preparation and pharmacological uses
04/04/2012CN101217957B 2,3 substituted pyrazine sulfonamides as inhibitors of CRTH2
04/03/2012US8148540 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
04/03/2012US8148535 Potassium channel inhibitors
04/03/2012US8148531 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
04/03/2012US8148525 2,4-pyrimidinediamine compounds and their uses
04/03/2012US8148521 Arthropodicidal anthranilamides
04/03/2012US8148422 Sulfonamides as TRPM8 modulators
04/03/2012US8148413 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
04/03/2012US8148404 Modulators of CB1 receptors
04/03/2012US8148403 Substituted piperidyl-propane-thiols
04/03/2012US8148402 Isoindolinone derivatives having inhibitory activity against T-type calcium channel and method for preparation thereof
04/03/2012US8148401 Benzimidazole derivatives
04/03/2012US8148398 Intermediate duration neuromuscular blocking agents and antagonists thereof
04/03/2012US8148397 5-HT7 receptor antagonists
04/03/2012US8148381 Potentiator of radiation therapy
04/03/2012US8148367 Renin inhibitors
04/03/2012US8148363 Heterocyclic compounds as factor IXA inhibitors
04/03/2012CA2674369C Fused substituted aminopyrrolidine derivative
04/03/2012CA2648157C 1-alkyl-5-aryl-3-arylamino-1h-1,2,4-triazoles as positive allosteric modulators of the alpha 7 receptor
04/03/2012CA2554187C 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines compound
04/03/2012CA2505427C Bicyclic-substituted amines as histamine-3 receptor ligands
03/2012
03/29/2012WO2012040258A2 Therapeutic piperazines
03/29/2012WO2012039561A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/29/2012WO2012039371A1 Cyclopropane compound
03/29/2012WO2012039141A1 6-acylpyridin-2-one derivative and herbicide
03/29/2012WO2012038944A1 Matrix metalloproteinase inhibitors
03/29/2012WO2012038942A1 Matrix metalloproteinase inhibitors
03/29/2012WO2012038904A1 Nicotinamide derivatives, preparation thereof and therapeutic use thereof
03/29/2012WO2012038521A1 Novel microbiocides
03/29/2012WO2012038081A1 Substituted benzamide compounds
03/29/2012WO2012007500A3 3-heterocyclyl-substituted pyridine compounds as pesticides
03/29/2012WO2011003641A3 Deodorants and antiperspirants having agents minimizing or inhibiting hair growth
03/29/2012US20120077982 Methods for Synthesizing 3-(Substituted Dihydroisoindolinone-2-YL)-2, 6-Dioxopiperidine, and Intermediates Thereof
03/29/2012US20120077981 N[s(4-aryl-triazol-3-yl)alpha-mercaptoacetyl]-p-amino benzoic acids as hiv reverse transcriptase inhibitors
03/29/2012US20120077974 Redox drug derivatives
03/29/2012US20120077967 Novel technetium and rhenium complexes
03/29/2012US20120077840 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
03/29/2012US20120077833 Acid addition salts of (3,5-bis trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide
03/29/2012US20120077821 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
03/29/2012US20120077820 Compounds and method for treatment of cancer
03/29/2012US20120077815 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors
03/29/2012US20120077812 Bicyclic compounds and use as antidiabetics
03/29/2012US20120077811 Prodrug forms of kinase inhibitors and their use in therapy
03/29/2012US20120077806 Deubiquitinase Inhibitors and Methods for Use of the Same
03/29/2012US20120077795 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077794 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077793 Compounds for the Treatment of Metabolic Disorders
03/29/2012US20120076835 Hiv inhibiting pyrimidines derivatives
03/29/2012US20120076756 Novel benzimidazole derivatives
03/29/2012CA2812362A1 Matrix metalloproteinase inhibitors
03/29/2012CA2812319A1 Matrix metalloproteinase inhibitors
03/29/2012CA2811895A1 Cyclopropane compounds
03/29/2012CA2811796A1 Substituted benzamide compounds
03/28/2012EP2433937A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/28/2012EP2433936A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/28/2012EP2433935A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/28/2012EP2432776A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
03/28/2012EP2432775A2 Substantially pure imatinib or a pharmaceutically acceptable salt thereof
03/28/2012EP2432768A1 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
03/28/2012EP2432765A1 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
03/28/2012EP2432764A1 Substituted quinolines for use as vegf inhibitors
03/28/2012EP2432762A1 Insecticidal arylpyrrolines
03/28/2012EP2432556A1 Protease inhibitors
03/28/2012EP2432554A1 Heterocyclic antiviral compounds
03/28/2012EP2432469A1 Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses
03/28/2012EP2148862B1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
03/28/2012EP2118087B1 Pi 3-kinase inhibitors and methods of their use
03/28/2012EP1956008B1 Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device
03/28/2012EP1951690B1 Heterocyclic cetp inhibitors
03/28/2012EP1694775B1 Reagent for detecting an analyte
03/28/2012EP1682537B1 Modulators of cellular adhesion
03/28/2012EP1603883B1 Quinoline-derived amide modulators of vanilloid vr1 receptor
03/28/2012EP1308438B9 3-substituted urea derivatives and medicinal use thereof
03/28/2012CN1960969B Histamine H3 receptor agents, preparation method and therapeutic uses thereof
03/28/2012CN1882568B Pyrrol derivatives with antibacterial activity
03/28/2012CN102395576A Jak kinase modulating quinazoline derivatives and methods of use thereof
03/28/2012CN102395575A P38map kinase inhibitor
03/28/2012CN102395574A Process for preparation of bezoyl amino heterocyclyl compounds
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 1080